INVESTIGADORES
RUGGIERO Melina
artículos
RUGGIERO, MELINA; BRICEÑO MUÑOZ, IVAN; GUTKIND, GABRIEL; HUJER, ANDREA M.; BONOMO, ROBERT A.; POWER, PABLO
Insights into the activity of cefiderocol against PER-2 producing Enterobacterales
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Año: 2024
RUGGIERO, MELINA; BRUNETTI, FLORENCIA; DABOS, LAURA; GIRLICH, DELPHINE; MUÑOZ, JACKSON IVAN BRICEÑO; CONZA, JOSÉ DI; POWER, PABLO; GUTKIND, GABRIEL; NAAS, THIERRY
Diversity of genetic platforms harboring the blaPER-2 gene in Enterobacterales and insights into the role of ISPa12 in its mobilization and dissemination.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS; Año: 2023
GONZALES-ESCALANTE, EDGAR; RUGGIERO, MELINA; CERDEIRA, LOUISE; ESPOSITO, FERNANDA; FONTANA, HERRISON; LINCOPAN, NILTON; GUTKIND, GABRIEL; DI CONZA, JOSE
Whole-Genome Analysis of a High-Risk Clone of Klebsiella pneumoniae ST147 Carrying Both mcr-1 and bla NDM-1 Genes in Peru
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE; Lugar: New York; Año: 2022
RUGGIERO, MELINA; PAPP-WALLACE, KRISZTINA M.; BRUNETTI, FLORENCIA; BARNES, MELISSA D.; BONOMO, ROBERT A.; GUTKIND, GABRIEL; KLINKE, SEBASTIÁN; POWER, PABLO
Structural insights into the inhibition of the extended-spectrum -lactamase PER-2 by avibactam
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Año: 2019 vol. 63
RUGGIERO, MELINA; GIRLICH, DELPHINE; DABOS, LAURA; POWER, PABLO; NAAS, THIERRY; GUTKINDA, GABRIEL
Complete sequence of the IncA/C1 plasmid pCf587 carrying blaPER-2 from citrobacter freundii
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Año: 2018 vol. 62
PAPALIA, MARIANA; TRAGLIA, GERMÁN; RUGGIERO, MELINA; ALMUZARA, MARISA; VAY, CARLOS; GUTKIND, GABRIEL; RAMÍREZ, SOLEDAD MARÍA; RADICE, MARCELA
Characterization of OXA-258 enzymes and AxyABM efflux pump from Achromobacter ruhlandii
Journal of Global Antimicrobial Resistance; Año: 2018
M. RUGGIERO; K. M. PAPP-WALLACE; M. TARACILA; M. MOJICA; C. BETHEL; S, RUDIN; E. ZEISER; G. GUTKIND; R. A. BONOMO; P. POWER
Exploring the Landscape of Diazabicyclooctane (DBO) Inhibition: Avibactam (AVI) Inactivation of PER-2 b-Lactamase
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Lugar: Washington; Año: 2017
M. RUGGIERO; L. CURTO; F. BRUNETTI; E. SAUVAGE; M. GALLENI; P. POWER; G. GUTKIND
Mutations at Arg220 and Thr237 in PER-2 b-lactamase: impact on conformation, activity and susceptibility to inhibitors
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Lugar: Washington; Año: 2017
A. RAMIREZ; M. RUGGIERO; C. ARANAGA; A. CATALDI; G. GUTKIND; J. H. DE WAARD; M. ARAQUE; P. POWER
Biochemical Characterization of b-Lactamases from Mycobacterium abscessus Complex and Genetic Environment of the b-Lactamase-Encoding Gene
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE; Lugar: New York; Año: 2016
M. RUGGIERO; F.KERFF; R. HERMAN; F. SAPUNARIC; M. GALLENI; G. GUTKIND; P. CHARLIER; E. SAUVAGE; P. POWER
Crystal Structure of the Extended-Spectrum Beta-Lactamase PER-2 and Insights into the Role of Specific Residues in the Interaction with Beta-Lactams and Beta-Lactamase Inhibitors
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Lugar: Washington; Año: 2014